Why large-volume blood transfusion can lower calcium through citrate

Why citrate is in the bag

Calcium is essential for blood clotting. To stop donated blood clotting during storage, blood services add a citrate-based anticoagulant solution. Citrate binds, or chelates, calcium in the bag, removing the free calcium that the clotting cascade needs. When the component is transfused, that citrate enters the client's circulation along with the blood.

In most transfusions this causes no problem. The liver, with help from muscle and kidneys, metabolises citrate rapidly into bicarbonate. Plasma and platelet components carry more citrate than red cells, because they contain more plasma. Modern resuscitation that uses balanced ratios of red cells, plasma and platelets therefore delivers a larger citrate load than older red-cell-focused practice. The nurse does not need to calculate citrate content, but recognising which products carry more helps explain why risk climbs during major haemorrhage.

When citrate overwhelms clearance

Problems arise when citrate enters faster than the body can clear it. Large-volume or massive transfusion, rapid infusion and exchange transfusion are typical settings. Clearance slows in liver failure, because the liver is the main site of citrate metabolism. Hypothermia and acidaemia also slow citrate metabolism, so the bleeding, cold, acidotic trauma client is at particular risk.

Excess circulating citrate binds the client's own ionised calcium, the active form. Total calcium may look less abnormal, so ionised calcium is the more useful measurement. Low ionised calcium in turn impairs clotting and heart muscle contraction, which can worsen bleeding and hypotension and lead to further transfusion, adding still more citrate in a harmful cycle.

Signs that prompt a calcium check

Early neuromuscular signs include tingling around the mouth and in the fingers and feet, and muscle cramps. As calcium falls further, the client may develop carpopedal spasm, a positive Chvostek or Trousseau sign, hyperreflexia, tetany, laryngospasm or seizures. In a sedated or anaesthetised client, these may not be reported, so monitoring depends more on measurements.

Cardiovascular signs include hypotension that responds poorly to volume and ECG changes such as a prolonged QT interval, with possible arrhythmias. During massive transfusion, these signs should prompt the nurse to ask for an ionised calcium level and alert the prescriber. Replacement is a prescriber or protocol decision; many massive transfusion protocols include scheduled ionised calcium checks.

Expected versus concerning trends and nursing actions

A client receiving one or two units at a standard rate with normal liver function is unlikely to develop citrate toxicity, and routine calcium checks are not usually needed. Concerning situations are large or rapid transfusion, liver disease, hypothermia or acidosis combined with new tingling, cramps, hypotension, arrhythmia or worsening bleeding.

Nursing actions include following the massive transfusion protocol for laboratory timing, using blood warming devices as directed to reduce hypothermia, monitoring ECG and blood pressure continuously, and reporting symptoms and results promptly. Keep track of total components given. Hypocalcaemia sits alongside other massive transfusion risks such as hyperkalaemia, hypothermia and coagulopathy, so the nurse watches them together.

Work a hypothetical scenario

A hypothetical trauma client with known cirrhosis is receiving rapid transfusion of red cells, plasma and platelets. They report tingling around the lips, blood pressure is falling despite products and the ECG shows a lengthening QT interval. Options include slowing all transfusion, treating it as anxiety, reporting and obtaining an ionised calcium level, or giving an antihistamine.

Reporting and obtaining an ionised calcium level is the best action, because liver disease and rapid transfusion favour citrate accumulation, and the symptoms fit hypocalcaemia. Slowing transfusion in a bleeding client may be unsafe. Anxiety and allergic reaction explanations miss the pattern. The scenario connects the preservative, the liver and the presenting signs.

Sources and further reading

MSD Manual Professional: Complications of transfusion. Citrate toxicity amplified by hypothermia, impaired citrate metabolism in liver failure, hypocalcaemia and associated hyperkalaemia and hypothermia risks.

MSD Manual Professional: Hypocalcemia. Transfusion of citrated blood as a cause, ionised calcium measurement, neuromuscular signs and QT prolongation.

Europe PMC: Impact of transfused citrate on pathophysiology in massive transfusion (Critical Care Explorations, 2023). Citrate chelation of calcium, hepatic metabolism, higher citrate in plasma and platelets, and slowed clearance with hypothermia and acidaemia.